Correlation Between AstraZeneca PLC and Santen Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Santen Pharmaceutical Co, you can compare the effects of market volatilities on AstraZeneca PLC and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Santen Pharmaceutical.
Diversification Opportunities for AstraZeneca PLC and Santen Pharmaceutical
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between AstraZeneca and Santen is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Santen Pharmaceutical go up and down completely randomly.
Pair Corralation between AstraZeneca PLC and Santen Pharmaceutical
Considering the 90-day investment horizon AstraZeneca PLC is expected to generate 1.82 times less return on investment than Santen Pharmaceutical. But when comparing it to its historical volatility, AstraZeneca PLC ADR is 2.15 times less risky than Santen Pharmaceutical. It trades about 0.03 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 964.00 in Santen Pharmaceutical Co on September 2, 2024 and sell it today you would earn a total of 97.00 from holding Santen Pharmaceutical Co or generate 10.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
AstraZeneca PLC ADR vs. Santen Pharmaceutical Co
Performance |
| Timeline |
| AstraZeneca PLC ADR |
| Santen Pharmaceutical |
AstraZeneca PLC and Santen Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AstraZeneca PLC and Santen Pharmaceutical
The main advantage of trading using opposite AstraZeneca PLC and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.| AstraZeneca PLC vs. Novartis AG ADR | AstraZeneca PLC vs. GlaxoSmithKline PLC ADR | AstraZeneca PLC vs. Roche Holding Ltd | AstraZeneca PLC vs. Bristol Myers Squibb |
| Santen Pharmaceutical vs. Sanofi ADR | Santen Pharmaceutical vs. Bristol Myers Squibb | Santen Pharmaceutical vs. AstraZeneca PLC ADR | Santen Pharmaceutical vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |